Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
Cannabis Act Regulations Indicative of Radient Technologies’ Role in Industrial-Scale Cannabis and Hemp Value Chains

2018-07-06 globenewswire
EDMONTON, Alberta, July 06, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI), is encouraged by Health Canada’s recently introduced Cannabis Regulations and Industrial Hemp Regulations in accordance with the Cannabis Act – a new legal framework that puts in place a comprehensive public health approach to cannabis in Canada.
ACB ACBFF RTI

30
Canadian Legalization: What's Next For Cannabis Stocks?

2018-06-21 seekingalpha
On June 19, 2018, the Canadian Senate passed The Cannabis Act 52 to 29. The rest of the approval process will be completed before the end of the week.
SNNVF KHRNF ACBFF RTI DTK CGC GSK LXX TWMJF ACB WEED RDDTF OGRMF OGI LXRP

0
Radient Technologies Inc. Files FDA Submission for Reducing Nicotine in Tobacco

2018-06-12 globenewswire
EDMONTON, Alberta, June 12, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce that it has made a submission to the U.S. Food and Drug Administration (the “FDA”) to consider the Company’s proprietary technology as a method to reduce nicotine levels in tobacco.
RTI

9
Aurora Cannabis Makes Strategic Investment in CTT Pharmaceutical

2018-05-22 globenewswire
Edmonton, AB, May 22, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CTT Pharmaceutical Holdings Inc. ("CTT") (US-OTC: CTTH) today announced that Aurora is acquiring an initial 9.14% ownership interest in CTT via way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling Aurora to increase ownership to 42.
ACB CTTH ACBFF RTI TXCX CNGGF

0
Weekly Cannabis Report: Aurora/MedReleaf, Canopy, Maricann

2018-05-15 seekingalpha
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis.
CRON RTI RDDTF CCAN MEDFF HMPPF

17
Aurora: Q3 2018, Another Solid Quarter Eclipsed By M&A Rumor

2018-05-10 seekingalpha
Revenue grew 38% driven by other revenue outside cannabis sales, which only increased 11% during the quarter.
TWMJF ACBFF WEED RTI LQSIF APHQF RDDTF CNGGF MEDFF HMPPF

0
Radient Technologies: A Cannabis And Hemp Extraction Expert

2018-05-06 seekingalpha
Since Radient acquired the MAP technology from Canadian Government the firm has struggled to commercialize the extraction process.
RTI HRVOF HMPPF

8
Radient Technologies - Excellent Growth Expected Over The Next Few Years

2018-05-05 seekingalpha
Radient continues to see steady revenue growth. The company also has excellent cash on hand to continue to grow its operations.
ACB ACBFF RTI RDDTF

8
Radient Technologies Inc. Announces Closing of Real Estate Transactions

2018-05-03 globenewswire
EDMONTON, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce it has completed its previously announced real estate acquisitions (please see the Company’s April 18, 2018 news release).
ACB ACBFF RTI

0
BRIEF-Radient Technologies Finalizes Real Estate Transactions For Expansion

2018-04-18 reuters
* RADIENT TECHNOLOGIES - PURSUANT TO JV DEAL, CO AGREED TO ISSUE 1.3 MILLION SHARES, AT DEEMED PRICE OF $1.40, TO VENDOR FOR 100% OWNERSHIP IN JV
RTI

8
Radient Technologies Inc. Finalizes Real Estate Transactions for Expansion and Provides Corporate Update

2018-04-18 globenewswire
EDMONTON, Alberta, April 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce the following update on its operations and 2018 growth initiatives.
ACB ACBFF RTI

20
A Look at Aurora Cannabis’s Partnerships

2018-04-06 editors.aws.marketrealist
Aurora Cannabis (ACB) (ACBFF), similar to Canopy Growth (WEED), has made several investments over the last two years.
TWMJF ACB WEED ACBFF RTI

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

7h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to TSXV:RTI / Radient Technologies Inc on message board site Silicon Investor.

Point and Figure Charting Microcap Potential Homeruns--Credible, and Reporting
Robotics and Artificial Intelligence Novartis
Lockheed Martin (LMT) The abortion issue: pro-choice vs. anti-abortion
Naked Shorting-Hedge Fund u0026 Market Maker manipulation? GOPwinger Lies/Distortions/Omissions/Perversions of Truth
Donald Trump is a fraud and a Con Artist - not a conservativ Fertilizer African Plays (PCP.V, FED.V)